NEW YORK--(BUSINESS WIRE)--
Deutsche Bank announced today its appointment as depositary bank for the Global Depositary Receipt (“GDR”) program of Lepu Medical Technology (Beijing) Co., Ltd. The GDRs are listed on the SIX Swiss Exchange under the symbol “LEPU”.
Lepu Medical Technology (Beijing) Co., Ltd. (“Lepu”) is a provider of medical devices, pharmaceuticals, and medical care solutions across the life cycle of cardiovascular disease management. Lepu is headquartered in Beijing, P.R. China and its A shares are listed and traded on the Shenzhen Stock Exchange under the stock code 300003.SZ.*
In addition to specializing in administering cross-border equity structures such as New York Shares and American and Global Depositary Receipts, Deutsche Bank provides corporates, financial institutions, hedge funds and supranational agencies around the world with trustee, agency, escrow and related services. Deutsche Bank offers a very broad range of services for diverse products, from complex securitizations and project finance to syndicated loans, debt exchanges and restructurings.
* This information was provided by Lepu Medical Technology (Beijing) Co., Ltd.(September 2022).
Depositary Receipt Information
Country
Incorporated under the laws of People’s Republic of China
Deutsche Bank provides commercial and investment banking, retail banking, transaction banking and asset and wealth management products and services to corporations, governments, institutional investors, small and medium-sized businesses, and private individuals. Deutsche Bank is Germany’s leading bank, with a strong position in Europe and a significant presence in the Americas and Asia Pacific.
